DK1057814T3 - Tetrahydrobenzindolderivater - Google Patents

Tetrahydrobenzindolderivater

Info

Publication number
DK1057814T3
DK1057814T3 DK98961493T DK98961493T DK1057814T3 DK 1057814 T3 DK1057814 T3 DK 1057814T3 DK 98961493 T DK98961493 T DK 98961493T DK 98961493 T DK98961493 T DK 98961493T DK 1057814 T3 DK1057814 T3 DK 1057814T3
Authority
DK
Denmark
Prior art keywords
hydrogen atom
integer
group
specified substituent
lower alkyl
Prior art date
Application number
DK98961493T
Other languages
Danish (da)
English (en)
Inventor
C Meiji Seika Kaisha L Kikuchi
T Meijiseika Kaisha Ltd Ando
K Meiji Seika Kaisha Ltd Fuji
M Meiji Seika Kaisha Ltd Okuno
O Meiji Seika Kaisha Ushiroda
M Meiji Seika Kaisha Lt Koyama
T Meija Seika Kaisha Hiranuma
E Meiji Seika Kaisha Lt Morita
M Meiji Seika Kaisha Ltd Imai
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP35838197A external-priority patent/JPH11189585A/ja
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of DK1057814T3 publication Critical patent/DK1057814T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92—Naphthostyrils
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
DK98961493T 1997-12-25 1998-12-22 Tetrahydrobenzindolderivater DK1057814T3 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP35838197A JPH11189585A (ja) 1997-12-25 1997-12-25 ５−ｈｔ７受容体結合能を有するテトラヒドロベンズインドール誘導体
JP35838097 1997-12-25
JP8591398 1998-03-31
JP13687298 1998-05-19
JP22970998 1998-08-14
JP31933698 1998-11-10
EP98961493A EP1057814B1 (en) 1997-12-25 1998-12-22 Tetrahydrobenzindole derivatives
PCT/JP1998/005827 WO1999033804A1 (fr) 1997-12-25 1998-12-22 Derives de tetrahydrobenzindole

Publications (1)

Publication Number Publication Date
DK1057814T3 true DK1057814T3 (da) 2005-07-04

Family

ID=27551662

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98961493T DK1057814T3 (da) 1997-12-25 1998-12-22 Tetrahydrobenzindolderivater

Country Status (12)

Country Link
US (1) US6498251B1 (zh)
EP (1) EP1057814B1 (zh)
JP (1) JP4459437B2 (zh)
KR (1) KR100588249B1 (zh)
CN (1) CN1129578C (zh)
AT (1) ATE290527T1 (zh)
CA (1) CA2316388C (zh)
DE (1) DE69829317T2 (zh)
DK (1) DK1057814T3 (zh)
ES (1) ES2238778T3 (zh)
NO (1) NO317293B1 (zh)
WO (1) WO1999033804A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407112B1 (en) * 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
GB9828004D0 (en) * 1998-12-18 1999-02-10 Smithkline Beecham Plc Use
AU1025601A (en) * 1999-10-18 2001-04-30 Smithkline Beecham Plc Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists
AR035417A1 (es) * 2001-01-27 2004-05-26 Hoffmann La Roche Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
WO2004018432A1 (en) * 2002-08-20 2004-03-04 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
WO2005012310A1 (ja) * 2003-08-04 2005-02-10 Soda Aromatic Co.,Ltd. チエノピリジン系化合物の香料における使用、および新規チエノピリジン系化合物
NZ551543A (en) * 2004-05-11 2009-12-24 Egis Gyogyszergyar Nyrt Pyridine derivatives of alkyl oxindoles as 5-HT7 receptor active agents
DE602006012650D1 (de) * 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
EP2054416B8 (en) * 2006-08-04 2014-07-16 Merz Pharma GmbH & Co. KGaA Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
EP1956006A1 (en) 2007-02-06 2008-08-13 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands
EP1975161A1 (en) * 2007-03-28 2008-10-01 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments
US8338447B2 (en) 2008-03-24 2012-12-25 Medivation Technologies, Inc. Pyrido[3,4-B]indoles and methods of use
EP2480079A4 (en) * 2009-09-23 2015-04-08 Medivation Technologies Inc PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR
CN108623585B (zh) * 2018-05-22 2021-07-09 中国人民解放军第二军医大学 β-四氢咔啉类抗真菌药物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733427T2 (de) 1996-06-28 2006-04-27 Meiji Seika Kaisha Ltd. Tetrahydrobezindol derivate
US6407112B1 (en) 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative

Also Published As

Publication number Publication date
KR100588249B1 (ko) 2006-06-13
ES2238778T3 (es) 2005-09-01
NO317293B1 (no) 2004-10-04
WO1999033804A1 (fr) 1999-07-08
DE69829317D1 (de) 2005-04-14
EP1057814B1 (en) 2005-03-09
NO20003285D0 (no) 2000-06-22
CN1286683A (zh) 2001-03-07
US6498251B1 (en) 2002-12-24
DE69829317T2 (de) 2006-04-06
CA2316388A1 (en) 1999-07-08
JP4459437B2 (ja) 2010-04-28
KR20010033609A (ko) 2001-04-25
NO20003285L (no) 2000-08-23
EP1057814A1 (en) 2000-12-06
ATE290527T1 (de) 2005-03-15
CA2316388C (en) 2009-09-08
EP1057814A4 (en) 2001-07-11
CN1129578C (zh) 2003-12-03

Similar Documents

Publication Publication Date Title
DK1057814T3 (da) Tetrahydrobenzindolderivater
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
FI950016A0 (fi) Heterosykliset yhdisteet lääkeaineena
EA200800285A1 (ru) Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk
BG105781A (en) Piperidine, tetrahydropyridine and piperazine derivatives, their preparartion and use
ATE186724T1 (de) Substituierte thiazolidindionderivate
ATE503746T1 (de) Neue imidazolidinderivate
WO2004089366A8 (en) Bicyclic compounds as nr2b receptor antagonists
ATE88714T1 (de) 2&#39;-desoxy-5-fluoruridinderivate.
FI940229A (fi) Trisykliset kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
DE69202120T2 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
DE69937045D1 (de) Cyclische amidderivate
AR005120A1 (es) Derivados 4-(1h-benzimidazol-2-il) [1,4]diazepanos substituidos utiles para el tratamiento de enfermedades alergicas, composicion farmaceutica y usos en la fabricacion de medicamentos.
ATE246682T1 (de) Benzothiazinderivate
ES2033523T3 (es) Un derivado de tioformamida.
DE69830600D1 (de) Anilidverbindungen und medikamente, die diese enthalten
DK0390138T3 (da) Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel
DE69222143D1 (de) Indanderivate
DE69626624D1 (de) Medikamente gegen trhombocytopenie
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
HUT76276A (en) 3-substituted 1-arylindole compounds, pharmaceutical compositions containing them and their use
TH60675A (th) การใช้อนุพันธ์ไพริโดอินโดโลนสำหรับการเตรียมผลิตภัณฑ์ยา